Lipids and Carbohydrates Flashcards
1
Q
Review of lipids
- Lipoproteins contain
- Lipoprotein classes determined by, #
- Lipid metabolism
A
- Lipoprotein contain
- cholesterol
- TG
- phospholipids
- apolipoprotein
- 5 different lipoprotein classes based on proportions of above constituents
- Ingested lipids are internalized by small bowel enterocytes and packaged into chylomicrons
- Chylomicrons transport lipid from enterocytes to hepatocytes into which they are endocytosed via apolipoprotein E
- In liver, cholesterol and TG undergo metabolism before being packaged into VLDL
- VLDL is vehicle for transport into bloodstream
- in blood the TGs in VLDL undergo hydrolysis by the endothelium bound lipoprotein (LPL) producing IDL and eventually LDL
- LDL is vehicle for transporting cholesterol from bloodstream to somatic cells where LDL undergoes endocytosis mediated by LDL receptor and apolipoprotein B100
- liver also produces HDL, a scavenger of cholesterol
2
Q
A
3
Q
Lipid measurements
- directly measured lipids
- how is LDL determined?
- how is VLDL determined?
- lipoprotein measurement performed how?
- lipoprotein electrophoresis
- gross characteristics of lipid specimen
A
- Directly measured lipids:
- total cholesterol
- HDL
- TG
- LDL is calculated
- VLDL cholesterol is estimated as TG/5 in mg/dL or TG/2.2 in mmol/L
- invalid when
- TG>400 mg/dL
- chylomicrons present
- beta VLDL characteristic from type III dyslipidemia
- invalid when
- Ultracentrifugation is used for lipoprotein measurement in reference labs
- lipoprotein electrophoresis:
- chylomicrons do not move from point of application
- LDL migrates to beta
- VLDL migrates to preBeta
- HDL migrates to alpha
- Overnight refrigeration produces pattern
- creamy layer on top of plasma indicates excess chylomicrons
- turbidity or opacity of plasma indicates abundant VLDL
- LDL and HDL even when present in excess do not visibly alter plasma
4
Q
LDL calculation
A
- Friedewald equation
- not valid if
- TG > 400
- chylomicrons present
- cholestasis
- type III dyslipidemia
5
Q
General features of lipid disorders
- consequence of hyperlipidemia (LDL versus TG)
A
-
Increased LDL or IDL
- Premature atherosclerosis
- xanthelasma (yellow periorbital papules)
-
Increased TG (chylomicrons or VLDL)
- eruptive xanthomas
- acute pancreatitis, particularly when TG>500 mg/dL
6
Q
A
7
Q
Predominant hypercholesterolemia
- cholesterol level
- primary causes
- secondary causes
A
- Plasma total cholesterol exceeds 200 mg/dL
- Usually related to elevated LDL
- Most common primary cause of hypercholesterolemia is familial hypercholesterolemia (AD) - deficiency of LDL receptors or LDL receptor activity
- Secondary causes of hypercholesterolemia:
- hypothyroidism
- diabetes mellitus
- nephrotic syndrome
- cholestasis
- cyclosporine
- thiazide diuretics
- loop diuretics
8
Q
Predominant hyperTG
- secondary causes
- primary causes
A
- Related to elevated chylomicrons or VLDL
- Secondary causes
- heavy alcohol use
- obesity
- diabetes mellitus
- hepatitis
- pregnancy
- renal failure
- beta blockers
- isotretinoin
- corticosteroids
- nephrotic syndrome
- gout
- Primary causes
- familial combined hyperlipidemia
- familial LPL deficiency
- familial apo C II deficiency
- familial hyperTG
9
Q
Mixed hyperTG and hypercholesterolemia
A
- most common in
- severe diabetes
- hypothyroidism
- nephrotic syndrome
- thiazides
- loop diuretics
- beta blockers
- primary causes
- familial combined hyperlipidemia
- type III hyperlipidemia (dysbetalipoproteinemia)
10
Q
Low levels of HDL cholesterol
A
- HDL < 35 mg/dL
- independent risk factor for premature atherosclerosis
- Tangier disease:
- autosomal recessive disorder
- low cholesterol
- normal to increased TG
- absent HDL
- absence of Apo A1
- cholesterol esters deposit in the tonsils, lymph nodes, vasculature, and spleen
- corneal opacities
- secondary causes
- smoking
- obesity
- sedentary lifestyle
- anabolic steroids
11
Q
Lipids in the assessment of coronary artery disease
- major risk factors for CAD
- testing
- recommendations
A
- Third Adult Treatment Panel report (ATP III) lists major risk factors for CAD:
- smoking
- HTN
- low HDL
- family history of premature CAD
- age >45 years for men and > 55 for women
- ATP III recommends fasting lipoprotein profile (including total cholesterol (TC), LDL, HDL, and TG for all patients)
- ATP III recommends specific cholesterol and LDL targets
12
Q
ATP III cholesterol classification
A
13
Q
ATP III Recommended LDL targets according to risk group
Notes
Target LDL
A
14
Q
C peptide
- C peptide: insulin
- major clinical use of C peptide
- what happens when blood is left in an unseparated test tube?
- whole blood versus plasma glucose
- how does glycosylated hemoglobin form?
A
- C peptide: insulin is 5-15:1 when both are expressed in SI units: pmol/L
- major clinical use of C peptide measurement is in detection of exogenous insulin administration
- when blood is left in an unseparated test tube, glycolysis will reduce the glucose by 5-10 mg/dL/hour depending on temp and WBC count
- sodium fluoride arrests this process for 24 hours
- initial arrest of glycolysis takes 1-2 hours so there will be a 5-10 mg/dL decrement
- uncalibrated whole blood glucose usually runs 10-15% lower than plasma glucose (depending on hct)
- glycosylated hemoglobin is formed when hemoglobin undergoes nonenzymatic reaction with glucose
15
Q
Glycosylated hemoglobin
A
- HgbA1c is one type, normal is < 6%
- HgbA1C depends on the concentration of serum glucose and the lifespan of the red cells (shortened red cell survival leads to relatively decreased HgbA1c)
- HgbA1c is an indicator of glucose concentrations over the preceeding 3 months
- HgbA1c can be translated into average blood glucose (AG) through the use of a formula: